11 results · 28ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Etiometry Platform (DAV 5.4 RAE 9.2)

FDA 510(k)
FDA Class 2 ·Cardiovascular

DemeMASK

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

KANGAROO ENTERAL FEEDING SET WITH ENFIT CONNECTORS

FDA 510(k)
FDA Class 2 ·General Hospital

NOVOPEN 3

FDA Adverse Event
Injury ·NOVO NORDISK A/S - MEDICAL SYSTEMS·Product code FMF·April 19, 2005

BD RAPID DETECTION OF SARS-COV-2 VERITOR ASSAY

FDA Adverse Event
Malfunction ·BECTON, DICKINSON & CO. (SPARKS)·Product code QKP·November 4, 2020

IMPL TAPERED SCR-V SBM 3.7MM 3.5MM 13MM

FDA Adverse Event
Injury ·ZIMMER DENTAL·Product code DZE·November 4, 2024

IMPL TAPERED SCR-V SBM 3.7MM 3.5MM 13MM

FDA Adverse Event
Injury ·ZIMMER DENTAL·Product code DZE·November 4, 2024

PARADIGM REAL-TIME INSULIN INFUSION PUMP

FDA Adverse Event
Malfunction ·MEDTRONIC MINIMED·Product code OYC·November 10, 2014

LIBERTY CYCLER SET, DUAL PATIENT CONNECT

FDA Adverse Event
Malfunction ·REYNOSA MANUFACTURING·Product code FKX·August 19, 2011

ENERGEN

FDA Adverse Event
Malfunction ·GUIDANT CRM CLONMEL IRELAND·Product code LWS·July 22, 2013

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014